Regulonix LLC
Gainesville, FL
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2878 SW 106th St, Gainesville, FL 32608, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
About the company
Regulonix LLC is a for-profit limited liability company that provides research and development services to the federal government through grant awards from the National Institutes of Health (NIH). Regulonix partners with universities and other organizations to discover and develop novel therapeutics, with a focus on treating chronic pain conditions.
Through prime and sub federal grant awards, Regulonix has provided research services aimed at identifying and characterizing potential drug candidates that target mechanisms involved in neuropathic and chemotherapy-induced peripheral neuropathy pain. Specifically, Regulonix has performed in vitro and in vivo efficacy studies, early ADME profiling, off-target screening, and preclinical pain model testing on compounds targeting neuropilin-1 receptors, T-type calcium channels, and N-type calcium channels. Regulonix has partnered with the University of Arizona under NIH National Institute of Neurological Disorders and Stroke and National Cancer Institute grant programs. Additionally, Regulonix has received direct NIH National Institute on Drug Abuse and National Institute of Neurological Disorders and Stroke grants to optimize lead compounds and compound series for advancement as non-addictive chronic pain therapies.
Quick answers
Is Regulonix LLC registered in SAM.gov?
Yes. Regulonix LLC's SAM.gov registration is active through July 8, 2027.
What is Regulonix LLC's CAGE code?
Regulonix LLC's CAGE code is 7HRZ9, and its Unique Entity ID (UEI) is RZ32MNG7DH93.
What is Regulonix LLC's most recent federal award?
Regulonix LLC's most recent federal grant award is Targeting the neuropilin-1 receptor (NRP-1)/vegf-a axis for neuropathic pain (R41NS122545), from National Institute of Neurological Disorders and Stroke (NIH), on September 1, 2021.
On GovTribe
See Regulonix LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors